Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma

Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

(2021) Chen Huang et al.   CANCER CELL

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

(2020) Anthony R. Cillo et al.   IMMUNITY

B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression

(2020) Ruoqin Wang et al.   Cell Death & Disease

Large-scale public data reuse to model immunotherapy response and resistance

(2020) Jingxin Fu et al.   Genome Medicine

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma

(2020) Zi Mei et al.   International Journal of Oral Science

An update on the immune landscape in lung and head and neck cancers

(2020) Jennifer W. Carlisle et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Head and neck squamous cell carcinoma

(2020) Daniel E. Johnson et al.   Nature Reviews Disease Primers

Clinical update on head and neck cancer: molecular biology and ongoing challenges

(2019) Elham Alsahafi et al.   Cell Death & Disease

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

(2019) Ezra E. W. Cohen et al.   Journal for ImmunoTherapy of Cancer

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy

(2019) Madison Canning et al.   Frontiers in Cell and Developmental Biology

Immunotherapy for head and neck cancer: Recent advances and future directions

(2019) John D. Cramer et al.   ORAL ONCOLOGY

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

(2018) Kimio Yonesaka et al.   CLINICAL CANCER RESEARCH

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

(2018) Peixin Dong et al.   Frontiers in Oncology

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

(2018) Sanjeev Mariathasan et al.   NATURE

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

(2018) Peng Jiang et al.   NATURE MEDICINE

B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma

(2018) Ting-Ting Yu et al.   OncoTargets and Therapy

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

(2018) Miguel F. Sanmamed et al.   CELL

Expression of CD24 and B7-H3 in breast cancer and the clinical significance

(2017) Fang Cong et al.   Oncology Letters

B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis

(2016) Zhimeng Ye et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

(2016) E. Picarda et al.   CLINICAL CANCER RESEARCH

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer

(2016) Bo Jiang et al.   Oncotarget

Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

(2015) Lieping Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome

(2014) Vibeke A Ingebrigtsen et al.   BMC CANCER

B7-H3 overexpression in pancreatic cancer promotes tumor progression

(2012) XIN ZHAO et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

(2012) Wanjuan Yang et al.   NUCLEIC ACIDS RESEARCH